FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 40 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,523 | -23.3% | 1,830 | -10.5% | 0.00% | – |
| Q1 2024 | $13,715 | -36.5% | 2,044 | -38.9% | 0.00% | – |
| Q4 2023 | $21,582 | -3.8% | 3,346 | -25.4% | 0.00% | – |
| Q3 2023 | $22,425 | -52.9% | 4,485 | -33.7% | 0.00% | – |
| Q2 2023 | $47,604 | +2.8% | 6,762 | -9.5% | 0.00% | – |
| Q1 2023 | $46,320 | -9.5% | 7,471 | -6.9% | 0.00% | – |
| Q4 2022 | $51,180 | -24.7% | 8,022 | +1.1% | 0.00% | – |
| Q3 2022 | $68,000 | -41.9% | 7,932 | -7.7% | 0.00% | – |
| Q2 2022 | $117,000 | -7.9% | 8,593 | +2.9% | 0.00% | – |
| Q1 2022 | $127,000 | -48.2% | 8,352 | -22.0% | 0.00% | – |
| Q4 2021 | $245,000 | +55.1% | 10,708 | -5.8% | 0.00% | – |
| Q3 2021 | $158,000 | -45.1% | 11,371 | -57.8% | 0.00% | – |
| Q2 2021 | $288,000 | +101.4% | 26,977 | +148.0% | 0.00% | – |
| Q1 2021 | $143,000 | -35.0% | 10,878 | 0.0% | 0.00% | – |
| Q4 2020 | $220,000 | – | 10,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $10,822,000 | 10.05% |
| Flagship Pioneering Inc. | 12,674,120 | $108,744,000 | 4.58% |
| Birchview Capital, LP | 264,843 | $2,272,000 | 1.60% |
| Artal Group S.A. | 1,720,720 | $14,764,000 | 0.63% |
| Rockwood Wealth Management, LLC | 124,030 | $1,064,178 | 0.34% |
| Alphabet Inc. | 500,901 | $4,298,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $6,671,000 | 0.13% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 330,051 | $2,832,000 | 0.04% |
| Virtus ETF Advisers LLC | 8,258 | $71,000 | 0.03% |
| Point72 Asset Management, L.P. | 388,600 | $3,334,000 | 0.01% |